To meet the needs of this new era, Fujifilm has evolved into a comprehensive healthcare company, offering products in the fields of prevention, diagnostics and treatment.
With its wide range of technologies and expansive vision, Fujifilm leverages the products, services, and hard-earned expertise that is rooted in the development of photographic products to enhance the quality of life of people worldwide. The schematic below shows our extraordinary progress so far and points towards emerging innovations ahead.
Established FUJIFILM Kyowa Kirin Biologics – Joint Venture for Biosimilar
2012
Acquired SonoSite, Inc. and VisualSonics, Inc. – becoming FUJIFILM SonoSite and FUJIFILM VisualSonics
2013
Launched SonoSite X-Porte
2014
Clinical trials for cancer drug and Alzheimer's disease drug with MD Andersen Cancer Center and Alzheimer's Disease Cooperative Study respectively begin in the US
2014
Launched Virtual Grid®, a new image processing tool
2014
Launched Apollo™ Mammalian Expression Platform
2014
Launched ASPIRE™ Cristalle digital mammography system
2014
Launched SonoSite iViz ultrasound system
2014
Acquired Japan Tissue Engineering Co., Ltd.
2014
Acquired Kalon Biotherapeutics – becoming FUJIFILM Diosynth Biotechnologies Texas
2015
Acquired Cellular Dynamics International, a leading developer and manufacturer of iPSC – becoming FUJIFILM Cellular Dynamics, Inc
2015
Acquired TeraMedica a leading provider of vendor neutral archive solutions
2015
Launched Synapse® VNA (Vendor Neutral Archive)
2015
Launched FDR D-EVOTM II, digital radiography detector
2016
Established FUJIFILM New Development U.S.A., Inc
2016
Established a Joint Venture with Opsis Therapeutics
2017
Launched Saturn mAb Platform™
2017
Launched BLI (Blue Light Imaging) Technologies for endoscopy
2017
Launched Dynamic Visualization™ II, an image processing technology
2017
Launched VisualSonics Vevo® MD, ultra-high frequency ultrasound
2017
Launched ASPIRETM Cristalle digital mammography with digital breast tomosynthesis
2017
Launched Synapse® 5 PACS
2017
Acquired Wako Pure Chemical Industries, a leading reagent manufacturer.